The Importance of Decentralized Clinical Trials.
Alongside COVID, most sponsors saw a significant shift to a more patient-centric approach in 'decentralized clinical trials'. But what does this mean for the future industry? Click to read more.
What are organisations doing to improve diversity in clinical trials? Click to find out what a panel of CRO leaders had to say in our latest live webinar. Now available as a podcast.
While our industry has continued to raise awareness about the lack of diversity within clinical trials, actually addressing the issue remains our biggest challenge. Click to read how some leaders are addressing this.
In this episode of CM Conversations, our guest share his tips on hitting the ground running and building a team remotely, as well as the importance of investing in relationships. In his words, you should always be visible and available.
In this clip, I talk about how acting fast is crucial to securing the very best talent in life sciences.
In this clip, I talk about how small companies can beat the larger corporations for talent. They just need to show off what makes them different, that they're people-focused and they can be flexible.
In this live episode, join life science recruitment experts Eleanor Doolin and Adam Butler as they discuss how the best businesses from across the life science space are winning the war for talent.
Every industry ground to a halt in March 2020 as COVID-19 swept the world. While some sectors were forced to shut down completely, clinical trial providers couldn’t simply stop. That would have meant years of research and funding gone to waste.
Innovative companies are trying to make a real difference for patients with rare diseases and address one of healthcare's largest unmet needs.
For this episode of CM Conversations, our Director of Operations Tom Maskill spoke with QIAGEN CEO Thierry Bernard.
Only 30% of executive positions and 18% of board seats are held by women in biotech. I spoke to an industry expert, Melissa Gammell, to find out where we're going wrong, how we get more women into biotech and how we keep them there.
In this episode of CM Conversations, our lab equipment specialist Lucy Smith spoke with Melissa Gammell, Vice President of Business Development at Matphil Technologies about the challenges facing women in biotech.
In this episode, our specialist in the lab equipment space, Lucy Smith, spoke with CEO of Elementar Americas Ryan Titmas. Lucy spoke to Ryan about what it takes to get to the top, as well as some of the lessons he’s learned in his career so far.
Coronavirus has provided us with a very large and extremely recent data set for research, patient populations and how different ethnic minorities are being affected versus the research. And the early indicators are that those from minority background
Decentralised, virtual, home, remote… whatever the name of this type of trial, it's widely agreed they will be crucial to advancing healthcare.
When I first made the decision to write an article about CRO size and what impact it has on service, the idea revolved around a ‘David vs Goliath’ narrative. I was going to write about major CROs compared to smaller CROs, then (spoiler alert) come...